http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-208248935-U

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b8e0fbf8a03666e8dca3366ca981045e
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/B65D81-113
filingDate 2018-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
grantDate 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c95ccb7d1d3af405bed3b290fa2f12ce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9eb9d8ad8fdbbc8d3de179a809d7449d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_4c7ff46f856e4435e9b3fdf48f15dcb9
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2dbd7885710f6677f11249065715dce
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d11792b60b0e2b1366d93769c09689c
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d1f6c36b9f71fd4e439dcdae7e4e414f
publicationDate 2018-12-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-208248935-U
titleOfInvention Abnormal cell screening reagent box in a kind of whole blood
abstract The utility model discloses abnormal cell screening reagent boxes in a kind of whole blood, including box body, the box body side is provided with the first box cover, the first box cover upper center is provided with limit plate, the limited mouth matched with limit plate is offered on one side end face of box portion outside, the tray interior upper end is fixedly installed fixing seat, immunomagnetic beads reagent bottle has been sequentially placed in box body by opening up opening in the fixing seat, fixating reagent bottle and elution reagent bottle, the fixing seat upper surface is provided with staining kit in immunomagnetic beads reagent bottle side, staining kit upper end side is provided with the second box cover, the first staining reagent bottle is disposed with by opening up opening in the staining kit, second staining reagent bottle, third staining reagent bottle.Quickly, capture rate is up to 95% or more, and the cell after capture is still active, can continue to cultivate, so as to carry out the experimental studies such as subsequent drug resistance for the utility model detection.
priorityDate 2018-04-02-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419554424
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2954

Total number of triples: 18.